ZCA
ANVS icon

Zeke Capital Advisors’s Annovis Bio ANVS Stock Holding History

Zeke Capital Advisors’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-27,594
Closed -$120K – 246
2020
Q2 		$120K Hold
27,594
– – 0.02% 199
2020
Q1 		$83K Buy
+27,594
New +$136K 0.02% 210

Other funds holding ANVS

WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
IA
Independence Advisors Wayne, Pennsylvania $466M AUM 11.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Zeke Capital Advisors's ANVS Position: Q3 2020 in Review

Zeke Capital Advisors sold out of Annovis Bio (ANVS) in Q3 2020, closing a stake of 27,594 shares — an estimated $120K sold.

Zeke Capital Advisors first reported a position in ANVS in Q1 2020 and held it in 2 quarters. The position peaked at $120K in Q2 2020. 12 funds tracked by Wall St. Rank hold ANVS as of Q3 2020.

  • Zeke Capital Advisors reported no remaining Annovis Bio position as of Q3 2020 after selling out during the quarter.
  • Zeke Capital Advisors sold 27,594 Annovis Bio shares in Q3 2020, an estimated $120K.
  • Zeke Capital Advisors first reported a position in Annovis Bio in Q1 2020 and held it in 2 quarters.
  • Zeke Capital Advisors's Annovis Bio position peaked at $120K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Annovis Bio as of Q3 2020.

Based on Zeke Capital Advisors's 13F filing for Q3 2020, filed 9 Nov 2020.